NovaBay Pharmaceuticals
6 hedge funds and large institutions have $708K invested in NovaBay Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
6
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$429K | |
| 2 | +$35K | |
| 3 | +$7K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$6K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3K |
Top Sellers
| 1 | -$30K | |
| 2 | -$10K | |
| 3 | -$9.93K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 5 |
Morgan Stanley
New York
|
-$1K |